Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Verastem, Inc. | 2,329,121 | reported | 12 Jun 2013 | tx 15+2,354,121−6,944,444 |
| MOMENTA PHARMACEUTICALS INC | 176,350 | reported | 10 Jun 2015 | tx 23+2,406,262−2,207,667 |
| aTYR PHARMA INC | 24,000 | reported | 22 May 2024 | tx 26+2,005,034−14,901,775 |
| CUBIST PHARMACEUTICALS INC | 12,500 | reported | 10 Jun 2004 | tx 3+18,600−6,100 |
| ALNYLAM PHARMACEUTICALS, INC. | 9,000 | reported | 20 Jun 2018 | tx 34+2,314,618−3,632,803 |
| VISICU INC | 0 | reported | 20 Feb 2008 | tx 46+7,538,846−3,822,423 |
| Sirtris Pharmaceuticals, Inc. | 0 | reported | 29 May 2007 | tx 8+2,073,470−10,885,714 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 22 May 2024 | GRANT_AWARD | aTYR PHARMA INC | 24,000 | 0.00 USD | deriv |
| 17 May 2023 | GRANT_AWARD | aTYR PHARMA INC | 12,000 | 0.00 USD | deriv |
| 26 Apr 2023 | EXERCISE | aTYR PHARMA INC | 6,000 | — | |
| 26 Apr 2023 | EXERCISE | aTYR PHARMA INC | 6,000 | 0.00 USD | deriv |
| 26 Apr 2022 | GRANT_AWARD | aTYR PHARMA INC | 6,000 | 0.00 USD | deriv |
| 21 May 2021 | SALE | aTYR PHARMA INC | 2,500 | 4.34 USD | |
| 28 Apr 2021 | GRANT_AWARD | aTYR PHARMA INC | 1,428 | 0.00 USD | deriv |
| 02 Sept 2020 | SALE | aTYR PHARMA INC | 7,260 | 4.01 USD | |
| 28 Aug 2020 | SALE | aTYR PHARMA INC | 100 | 4.00 USD | anomaly |
| 26 Aug 2020 | SALE | aTYR PHARMA INC | 2,200 | 4.30 USD | |
| 27 Aug 2020 | SALE | aTYR PHARMA INC | 5,440 | 4.09 USD | |
| 06 May 2020 | GRANT_AWARD | aTYR PHARMA INC | 1,428 | 0.00 USD | deriv |
| 08 May 2019 | GRANT_AWARD | aTYR PHARMA INC | 20,000 | 0.00 USD | deriv |
| 20 Jun 2018 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 9,000 | 0.00 USD | deriv |
| 31 May 2018 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 100 | 101.97 USD | |
| 31 May 2018 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 2,100 | 101.37 USD | |
| 31 May 2018 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 2,758 | 99.38 USD | |
| 31 May 2018 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 15,000 | 27.28 USD | |
| 31 May 2018 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 10,042 | 100.33 USD | |
| 31 May 2018 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 15,000 | 0.00 USD | deriv |
| 15 May 2018 | GRANT_AWARD | aTYR PHARMA INC | 20,000 | 0.00 USD | deriv |
| 02 Jun 2017 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 11,250 | 0.00 USD | deriv |
| 09 May 2017 | GRANT_AWARD | aTYR PHARMA INC | 20,000 | 0.00 USD | deriv |
| 03 Jun 2016 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 11,250 | 0.00 USD | deriv |
| 24 May 2016 | GRANT_AWARD | aTYR PHARMA INC | 18,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 01 Feb 2012.